Antitumor Efficacy of Temozolomide in Patients with Metastatic Pulmonary Carcinoids Abstract #1537

Introduction: Temodal (TMZ) is an oral alternative to dacarbazine.
Aim(s): The aim of this study was to retrospectively analyze the efficacy and safety of TMZ in patients with metastatic pulmonary carcinoids (mPC).
Materials and methods: 34 patients pathologically reviewed mPC according to the WHO criteria, referred to Gustave Roussy from 1993 to 2014 were included. Treatment was given at a dose of 150 mg/m2/day for 5 days (D1=D28), escalated to 200 mg/m2/day if well tolerated. Disease control rate, according to RECIST at 12 months was the primary endpoint. DCR was compared in patients who received both oxaliplatin-based chemotherapy (O-BC) i.e gemox or folfox, and dacarbazine (TMZ or deticene/DTIC-BC) in a subgroup of 16 patients referred to Gustave Roussy or Hospices Civils of Lyon.
Conference: 13th Annual ENETS conference (2016)
Category: Medical treatment - Chemotherapy
Presenting Author: Diana Bello Roufai

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1499 Efficacy of the Combination of Capecitabine and Temozolomide in Patients with Advanced Pulmonary Carcinoid Tumours
Introduction: Limited treatment options exist for patients (pts) with advanced pulmonary carcinoids (PC). Capecitabine-temozolomide (CAPTEM) has demonstrated significant efficacy in pts with pancreatic neuroendocrine tumours. However, its role in PC remains unexplored.
Conference: 13th Annual ENETS conference (2016)
Category: Medical treatment - Chemotherapy
Presenting Author: MD, PhD Georgios Papaxoinis
#2174 Clinicopathologic Features and Treatment Outcome of 225 Newly Diagnosed Pulmonary Carcinoids: A Single Center Experience of 28 Years
Introduction: Data on pulmonary carcinoids are scarce.
Conference: 15th Annual ENETS conference (2018)
Category: Non digestive NETs (bronchial, thymic, others) - diagnosis and therapy
Presenting Author: M.D. Hong Zhao
Authors: Li Q, Zhou Y, Zhang Y, Chi Y, ...
#1080 Evaluation of the Combination Oxaliplatin and 5-Fluorouracil or Gemcitabine in Patients with Metastatic Lung Carcinoid Tumors
Introduction: -
Conference: 12th Annual ENETS Conference (2015)
Category: Medical treatment - Chemotherapy
Presenting Author: MD, PhD Thomas Walter
Keywords: gemox, folfox, lung, carcinoid
#1244 Everolimus in Progressive Metastatic Pancreatic Neuroendocrine Tumors: Analyses of Median Progression Free Survival and Safety in the Real Life Setting
Introduction: Everolimus is an oral inhibitor of mammalian target of rapamycin(mTOR) with antitumor activity in patients(pts) with pancreatic neuroendocrine tumor(pNET)s
Conference: 12th Annual ENETS Conference (2015)
Category: Medical treatment - Targeted therapies
Presenting Author: Michela Del Prete
#1298 Temozolomide-based Second-line Chemotherapy in Patients with Advanced Bronchopulmonary Neuroendocrine Tumours
Introduction: The management of advanced Bronchopulmonary Neuroendocrine Tumours (BP-NET) is not standardized. There are only few clinical studies of Temozolomide (TMZ) as monotherapy or in combination with other agents available for BP-NET.
Conference: 13th Annual ENETS conference (2016)
Category: Medical treatment - Chemotherapy
Presenting Author: PhD Elizaveta Tabaksblat
Authors: Tabaksblat E, Ladekarl M, ...